Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026)

Ginkgo Bioworks Holdings (DNA) posted Assets Average of $1.1 billion for Q1 2026, down 6.76% on a QoQ basis from $1.2 billion in Q4 2025, and down 19.4% year-over-year from $1.3 billion in Q1 2025.

Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings' Assets Average history runs 6 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

  • Quarterly Assets Average fell 19.4% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 19.4% YoY) and the FY2025 annual result came in at $1.2 billion, down 17.93% from the prior year.
  • Assets Average was $1.1 billion for Q1 2026 at Ginkgo Bioworks Holdings, down from $1.2 billion in the prior quarter.
  • Across five years, Assets Average topped out at $2.5 billion in Q1 2023 and bottomed at $1.1 billion in Q1 2026.
  • A 5-year average of $1.7 billion and a median of $1.6 billion in 2024 frame the typical range for Assets Average.
  • Annual changes were most pronounced in 2022 — Assets Average surged 71.8% — and 2024, when it slumped 34.49%.
  • Ginkgo Bioworks Holdings' Assets Average stood at $2.2 billion in 2022, then slipped by 16.29% to $1.8 billion in 2023, then retreated by 22.57% to $1.4 billion in 2024, then declined by 19.22% to $1.2 billion in 2025, then dropped by 6.76% to $1.1 billion in 2026.
  • Business Quant data shows DNA's Assets Average at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 303.40 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 65.01 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.37 Bn
4 NuCana 279.75 Bn 279.75 Bn - 41.64 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.06 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.71 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.91 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.30 Bn
10 Ginkgo Bioworks Holdings 517.16 Mn 373.30 Mn 16.38 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.15 Bn
Sep 30, 2025 1.21 Bn
Jun 30, 2025 1.26 Bn
Mar 31, 2025 1.34 Bn
Dec 31, 2024 1.43 Bn
Sep 30, 2024 1.55 Bn
Jun 30, 2024 1.60 Bn
Mar 31, 2024 1.62 Bn
Dec 31, 2023 1.85 Bn
Sep 30, 2023 2.16 Bn
Jun 30, 2023 2.35 Bn
Mar 31, 2023 2.48 Bn
Dec 31, 2022 2.21 Bn
Sep 30, 2022 1.93 Bn
Jun 30, 2022 2.03 Bn
Mar 31, 2022 2.06 Bn
Dec 31, 2021 2.11 Bn
Sep 30, 2021 1.94 Bn
Jun 30, 2021 1.73 Bn